Stanford’s Karl Deisseroth Wins 2026 Nobel for Optogenetics, Sparking Global Praise

3 min read
Source: Stanford Medicine
Stanford’s Karl Deisseroth Wins 2026 Nobel for Optogenetics, Sparking Global Praise
Photo: Stanford Medicine
TL;DR

Karl Deisseroth, a Stanford professor of bioengineering and psychiatry, has won the 2026 Nobel Prize in Physiology or Medicine for his pioneering work in optogenetics. The award, announced on October 5, 2026, recognizes his development of a technique that uses light to control specific nerve cells in living brains. Deisseroth shares the prize with Peter Hegemann and Georg Nagel, with the three laureates splitting a total of 12 million Swedish crowns. The announcement triggered widespread celebration among his family, former students, and colleagues, who highlighted his relentless work ethic and generosity in sharing scientific tools. Deisseroth stated he plans to return immediately to research, emphasizing the need to continue discovering new treatments for neuropsychiatric disorders.

Key points

  • Karl Deisseroth, a Stanford University professor, won the 2026 Nobel Prize in Physiology or Medicine for developing optogenetics.
  • The prize was announced on October 5, 2026, and shared with Peter Hegemann and Georg Nagel.
  • Optogenetics allows scientists to activate or inhibit specific nerve cells using light, aiding in the study of brain circuits and disorders.
  • Deisseroth’s wife, Michelle Monje-Deisseroth, and his children expressed pride, with his 10-year-old daughter noting he had 'won all the prizes.'
  • Former students and colleagues, including Feng Zhang and Rob Malenka, praised Deisseroth’s mentorship, creativity, and commitment to making optogenetics accessible to the broader scientific community.
  • Stanford University leadership, including President Jonathan Levin and Dean Lloyd Minor, hailed Deisseroth as a defining figure in modern neuroscience.

Background

The 2026 Nobel Prizes have been a focal point for discussions on scientific achievement and diversity. In October 2026, Francis Halzen won the Physics Nobel for the IceCube neutrino telescope, and Henri B. Kagan and Kenso Soai won the Chemistry Nobel for solving the chirality mystery. Earlier in the month, Nature highlighted the persistent gender gap in science Nobels, noting that women remain underrepresented in these categories. Deisseroth’s award in Physiology or Medicine adds to the year’s recognition of groundbreaking scientific advancements, particularly in fields that bridge engineering and medicine.

Why it matters

Deisseroth’s Nobel Prize underscores the transformative impact of optogenetics on neuroscience and medicine. By enabling precise control of neural activity, this technique has opened new avenues for understanding brain function and developing treatments for psychiatric and neurological disorders. The award also highlights the importance of interdisciplinary collaboration, as Deisseroth’s work bridges bioengineering, psychiatry, and basic science. His decision to make optogenetics accessible to the global scientific community has accelerated research and innovation, demonstrating how shared knowledge can drive progress in complex fields like neuroscience.

What to watch

Deisseroth has indicated he will return to his research immediately, focusing on further discoveries and applications of optogenetics. The broader scientific community is expected to continue leveraging this technique to explore brain circuits and develop new therapies. Stanford University and other institutions may see increased collaboration and funding for projects related to optogenetics and neuropsychiatric disorders. Additionally, the award may inspire more interdisciplinary approaches in science, encouraging researchers to bridge fields like engineering and medicine to address complex biological challenges.

Share this article

Want the full story? Read the original reporting

Read on Stanford Medicine